1. Home
  2. YMT vs CRDF Comparison

YMT vs CRDF Comparison

Compare YMT & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YMT

Yimutian Inc. American Depositary Shares

N/A

Current Price

$1.37

Market Cap

172.7M

Sector

Technology

ML Signal

N/A

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$2.51

Market Cap

142.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMT
CRDF
Founded
2011
1999
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.7M
142.1M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
YMT
CRDF
Price
$1.37
$2.51
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.63
AVG Volume (30 Days)
45.9K
868.0K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,547,440.00
$501,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.68
N/A
52 Week Low
$1.00
$1.90
52 Week High
$6.05
$5.64

Technical Indicators

Market Signals
Indicator
YMT
CRDF
Relative Strength Index (RSI) N/A 63.72
Support Level N/A $2.09
Resistance Level N/A $2.49
Average True Range (ATR) 0.00 0.14
MACD 0.00 0.04
Stochastic Oscillator 0.00 83.33

Price Performance

Historical Comparison
YMT
CRDF

About YMT Yimutian Inc. American Depositary Shares

Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: